Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction

scientific article

Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/JAHA.115.001956
P932PMC publication ID4599491
P698PubMed publication ID26316523

P50authorNicholas L. MillsQ42405715
Marc R DweckQ57009695
James H RuddQ57077698
Alex T VeseyQ57192011
Keith FoxQ72227369
Iqbal ToorQ92233789
William S. JenkinsQ92678487
David E NewbyQ94451652
Neal UrenQ114309800
Shirjel R AlamQ116781999
P2093author name stringAnoop S V Shah
Edwin J R van Beek
Alison M Fletcher
Nikhil V Joshi
Adam J Melville
Andrew Sills
Kathryn Carruthers
Sarah P Langlands
Teng Y Hoo
P2860cites workPrediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)Q22242088
Identification of splenic reservoir monocytes and their deployment to inflammatory sitesQ24649151
Heart disease and stroke statistics--2011 update: a report from the American Heart AssociationQ29547236
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesionsQ33916802
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trialQ34120778
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.Q34132798
Atherosclerosis and leukocyte-endothelial adhesive interactions are increased following acute myocardial infarction in apolipoprotein E deficient mice.Q34188766
Third universal definition of myocardial infarctionQ34295914
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failureQ34322056
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.Q35552554
Myocardial infarction accelerates atherosclerosis.Q36106602
Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstructionQ36172904
The incidence of stroke after myocardial infarction: a meta-analysisQ36431878
Mechanisms of acute coronary syndromes and their implications for therapyQ38108628
Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis.Q38481051
Thoracic aortic calcium versus coronary artery calcium for the prediction of coronary heart disease and cardiovascular disease eventsQ38495624
Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxideQ39152434
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trialQ39315993
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biologyQ39627320
18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic diseaseQ39946694
A prospective natural-history study of coronary atherosclerosisQ41983924
Mechanisms of progression in native coronary artery disease: role of healed plaque disruption.Q42124769
Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable anginaQ43098198
Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation?Q43862047
Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarctionQ44237939
Ischemic stroke after acute myocardial infarction. A population-based studyQ44427240
Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.Q46000195
C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findingsQ46627635
Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study).Q46637686
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarctionQ47191457
Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodelingQ47785069
ST elevation acute myocardial infarction accelerates non-culprit coronary lesion atherosclerosis.Q51328588
Multiple Complex Coronary Plaques in Patients with Acute Myocardial InfarctionQ56775151
Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006Q57243464
Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)**Further information about the project, along with a complete listQ57243537
Preventive Angioplasty in Myocardial InfarctionQ58133716
C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarctionQ73606387
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patientsQ79328884
Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote arteryQ79734262
Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patientsQ79949667
Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography studyQ84330186
Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortalityQ84588574
Metabolic activity of the spleen and bone marrow in patients with acute myocardial infarction evaluated by 18f-fluorodeoxyglucose positron emission tomograpic imagingQ87218257
P433issue9
P921main subjectmyocardial infarctionQ12152
atherosclerosisQ12252367
acute myocardial infarctionQ18558122
P304page(s)e001956
P577publication date2015-08-27
P1433published inJournal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseQ19880670
P1476titleSystemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction
P478volume4

Reverse relations

cites work (P2860)
Q38660995A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases
Q59811795A novel fluorescein-bisphosphonate based diagnostic tool for the detection of hydroxyapatite in both cell and tissue models
Q38874840Air pollution and short-term clinical outcomes of patients with acute myocardial infarction
Q99709769Association of glucose uptake of visceral fat and acute myocardial infarction: a pilot 18F-FDG PET/CT study
Q59133072C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up
Q89574926Characterization of glucose uptake metabolism in visceral fat by 18 F-FDG PET/CT reflects inflammatory status in metabolic syndrome
Q89798553Clinical imaging of cardiovascular inflammation
Q52912755Editorial : Scoring and Other Assessments of Plaque Morphology and Pathology
Q90577485Greater aortic inflammation and calcification in abdominal aortic aneurysmal disease than atherosclerosis: a prospective matched cohort study
Q90455308Hepato-splenic axis: hepatic and splenic metabolic activities are linked
Q64056942IL-7R blockade reduces post-myocardial infarction-induced atherosclerotic plaque inflammation in ApoE−/- mice
Q45793264Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study
Q26764836Imaging Atherosclerosis
Q53028581Imaging biomarkers in the clinic.
Q38844535Imaging of coronary atherosclerosis - evolution towards new treatment strategies
Q92678491In vivo alpha-V beta-3 integrin expression in human aortic atherosclerosis
Q64066315Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction
Q92859238Inflammation in atherosclerotic cardiovascular disease
Q60306046Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction
Q58592672Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3)
Q51730474New methods to image unstable atherosclerotic plaques.
Q37082503Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis
Q26750798PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology
Q37050963Positron emission tomography imaging of coronary atherosclerosis
Q91893037Rosuvastatin Prevents the Exacerbation of Atherosclerosis in Ligature-Induced Periodontal Disease Mouse Model
Q92305993Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction
Q91599400miR-499 released during myocardial infarction causes endothelial injury by targeting α7-nAchR

Search more.